BioSpace News Archive

SUNFISH Part 1 showed risdiplam significantly improved motor function after 24 months of treatment in people aged 2-25 years with Types 2 or 3 SMA – – JEWELFISH study preliminary 12-month data in previously treated patients showed rapid and sustained increases in SMN protein levels trial – – Safety was consistent with the safety profile observed to date and no new safety signals were identified – SOUTH SAN FRANCISCO, Calif.--( BUSINESS

PTC Therapeutics, Inc. announced that on June 10, 2020 it approved non-statutory stock options to purchase an aggregate of 54,675 shares of its common stock and 3,940 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to five new employees.

Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15 th

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 386 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2020, to shareholders of record at the close of business on July 15, 2020 . Abbott has inc

Oceans Healthcare and the Massachusetts General Hospital Department of Psychiatry have signed an agreement that will give patients of the behavioral health network access to some of the world’s most highly qualified psychiatrists.

Q BioMed (OTC: QBIO) is proud to be a Supporter of the Living Beyond Breast Cancer (LBBC) 2020 Virtual Conference on Metastatic Breast Cancer taking place June 13 and 14, 2020.

Cancers cells use a special technique to propagate; they delete their “programmed death” gene through mutation, “forget” to die when their lifetime is over, and continue to grow instead

Foundation Medicine, Inc., today announced that it has completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel multiomics liquid biopsy platforms to advance cancer care.

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that its Board of Directors has appointed Mark J. Golden as CEO effective August 17.

Johnson & Johnson Consumer Health* today presented findings from the longest longitudinal study of infant and mother skin microbiome research at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020, from June 12 – 14, 2020.